Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Eli Lilly and Company    LLY

ELI LILLY AND COMPANY

(LLY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Eli Lilly and : Lilly to Participate in Evercore ISI 3rd Annual HealthCONx Conference

11/24/2020 | 03:01pm EST

INDIANAPOLIS, Nov. 24, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in the Evercore ISI 3rd Annual HealthCONx Conference on Tuesday, December 1, 2020. Michael Mason, Lilly senior vice president and president of Lilly Diabetes and Connected Care, will participate in a virtual fireside chat at 2:40 p.m., Eastern Time.  

A live audio webcast will be available on the "Webcasts & Presentations" section of Lilly's Investor website at https://investor.lilly.com/webcasts-and-presentations. A replay of the presentation will be available on this same website for approximately 90 days.

About Eli Lilly and Company
Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and http://newsroom.lilly.com/social-channels.  F-LLY   

Refer to:   

Mark Taylor; mark.taylor@lilly.com; (317) 276-5795 (Media)   


Kevin Hern; hern_kevin_r@lilly.com; (317) 277-1838 (Investors)

 

Eli Lilly and Company logo. (PRNewsfoto/Eli Lilly and Company)

Cision
View original content to download multimedia:http://www.prnewswire.com/news-releases/lilly-to-participate-in-evercore-isi-3rd-annual-healthconx-conference-301180058.html

SOURCE Eli Lilly and Company


© PRNewswire 2020
All news about ELI LILLY AND COMPANY
01/22ELI LILLY AND : BofA Securities Adjusts Eli Lilly and Company PT to $225 From $1..
MT
01/22ELI LILLY AND COMPANY : - Lilly's neutralizing antibody bamlanivimab prevented C..
AQ
01/21ELI LILLY AND : Says Trial of Monoclonal Antibody Among Nursing Home, Staff Resi..
MT
01/21ELI LILLY AND : Lilly's neutralizing antibody bamlanivimab (LY-CoV555) prevented..
AQ
01/21ELI LILLY AND : Says Late-Stage Trial Shows Antibody Bamlanivimab Effective in P..
MT
01/21Lilly Antibody Drug Prevents Covid-19 in Nursing Homes, Study Finds
DJ
01/21ELI LILLY AND : Lilly's neutralizing antibody bamlanivimab (LY-CoV555) prevented..
PR
01/21ELI LILLY AND : (LLY) Insider Makes Significant Share Sale
MT
01/20ELI LILLY AND : Thinking about trading options or stock in General Motors, Eli L..
PR
01/20FULCRUM THERAPEUTICS : Announces Promotion of Christopher Moxham Ph.D. to Chief ..
AQ
More news